Navigation Links
Many Older Men Won't Benefit from PSA Test
Date:2/20/2009

Screening may prove an unnecessary expense in men 75 or older, researchers say

FRIDAY, Feb. 20 (HealthDay News) -- Routine prostate specific antigen (PSA) blood tests offer no benefit to many men ages 75 to 80, a new study suggests.

Researchers analyzed data from 727 prostate cancer patients and 122 cancer-free men who took part in the U.S. National Institute on Aging's Baltimore Longitudinal Study of Aging and had regular PSA testing.

The Johns Hopkins-led study found that none of the men between 75 and 80 years old who had PSA levels lower than 3 nanograms per milliliter died of prostate cancer and only one developed aggressive prostate cancer. However, men of all ages with a PSA level of 3 nanograms per milliliter or higher had a continually rising risk of dying from prostate cancer.

The findings, published in the April issue of the Journal of Urology, suggest that many older men may no longer require PSA testing. If confirmed in future studies, the results may help determine more specific age-based guidelines for when it's safe to stop PSA screening, said lead investigator Dr. Edward Schaeffer, an assistant professor of urology at Johns Hopkins University School of Medicine.

PSA testing helps detect prostate cancer at the early stages and is credited with helping reduce prostate cancer deaths. But discontinuing unnecessary PSA testing in certain older men could help reduce screening costs and health problems caused by additional tests or treatments.

"We need to identify where we should best focus our health care dollars by concentrating on patients who can actually benefit from PSA testing. These findings give a very strong suggestion of when we can start to counsel patients on when to stop testing," Schaeffer said.

More information

The U.S. National Cancer Institute has more about PSA testing.



-- Robert Preidt



SOURCE: Johns Hopkins Medicine, news release, Feb. 20, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Prostate specific antigen testing may be unnecessary for some older men
2. MGT Capital Investments, Inc.: Failure to Satisfy a Continued Listing Rule Based on a Lack of Shareholder Meeting in 2008 and Medicsight Statement Regarding CMS Proposed Decision
3. NUCRYST Approves $0.80 Per Share Cash Distribution to Shareholders
4. MedClean Technologies Inc. CEO Publishes Letter to Shareholders
5. Cell Therapeutics Updates Shareholders on Trading
6. LCA-Vision Announces Consent Solicitation Deadline; Urges Stockholders to Return Gold Consent Revocation Card
7. PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy
8. The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders
9. Vitamins Do Older Women Little Good
10. AARP Survey Finds Middle-Aged & Older Americans Struggling in Economy
11. Volunteer work in grade schools produces persistent health benefit for older black women
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Many Older Men Won't Benefit from PSA Test
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: